Core Insights - Chanson International Holding has received official registration approval for its "Songkang Meal" series as a Food for Special Medical Purpose (FSMP) in China, marking its entry into the medical nutrition market [1][4] - The "Songkang Meal" is specifically designed for patients with chronic conditions, utilizing a low-glycemic index carbohydrate and plant-based protein blend, and has shown positive initial results in hospitals [2][4] - The company plans to leverage its existing supply chain and retail network to scale the FSMP product line nationwide, with ambitions to launch five new nutrition products by 2026 [4] Company Overview - Chanson International Holding, founded in 2009, operates bakery, seasonal, and beverage products through its chain stores in China and the United States, managing 63 stores in China and 3 in New York City [5] - The company focuses on creating healthy, nutritious, and ready-to-eat food, utilizing advanced facilities and in-depth industry research to meet customer demand [5] Product Development and Market Strategy - The "Songkang Meal" series incorporates local ingredients from Xinjiang, such as sea buckthorn and chickpeas, to enhance its nutritional profile and address regional market needs [2][3] - Chanson aims to achieve cost efficiency and raw material traceability by centralizing production in Xinjiang and utilizing local sourcing [3] - The company has established a logistics system capable of delivering FSMP products to hospital partners within 48 hours, addressing cold-chain distribution challenges [3]